I²DEAL stands for International Institute for Dermatological Allergology.
In 2012, the I²DEAL partnership between the Allergie-Centrum-Charité (ACC) and the global pharmaceutical company LEO Pharma A/S from Denmark was established. LEO Pharma as well as the
ACC are specialized in the research and treatment of skin diseases including the medication development in own labs. The focus is on profound research and treatment of unbearable itch that often comes with skin diseases. Itch is difficult to treat. There is still no reliable medication that grants complete relief. The research in this area is in its infancy.
I²DEAL is committed to promoting the research of allergic skin diseases in order to ease the suffering of many patients affected.
Within the scope of I²DEAL, basic scientific projects and clinical trials are carried out.
For more details please read our pages. If you have questions or suggestions, please do not hesitate to contact us.
The I²DEAL-Team